Verified Nov 2026
Other
·
Copenhagen, Capital Region of Denmark
·
Since 1903
Xellia Pharmaceuticals, headquartered in Copenhagen and founded in 1903, is a specialty pharmaceutical manufacturer with 1,000–5,000 employees. The company produces fermentation-based non-beta-lactam anti-infectives, active pharmaceutical ingredients, and injectable formulations, serving medical, healthcare, and critical-care sectors. In March 2026, Xellia acquired an industrial facility in Hungary to expand manufacturing capacity.
Xellia Pharmaceuticals at a glance
Revenue
$100-250M
Est. band
Employees
1,000-5,000
Founded
1903
Headquarters
Copenhagen, Capital Region of Denmark
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Overview
Xellia Pharmaceuticals, headquartered in Copenhagen and founded in 1903, is a specialty pharmaceutical manufacturer with 1,000–5,000 employees. The company produces fermentation-based non-beta-lactam anti-infectives, active pharmaceutical ingredients, and injectable formulations, serving medical, healthcare, and critical-care sectors. In March 2026, Xellia acquired an industrial facility in Hungary to expand manufacturing capacity.
At a glance
Attribute | Detail |
|---|---|
Founded | 1903 |
Headquarters | Copenhagen, Capital Region of Denmark |
Employees | 1,000-5,000 |
Revenue | $100-250M (estimated) |
What Xellia Pharmaceuticals makes
Xellia manufactures fermentation-based active pharmaceutical ingredients including vancomycin and colistimethate sodium, and provides contract manufacturing and finished injectable dosage forms for hospital use.
Latest developments
2026-10-07 — Novo Holdings-owned Xellia breaks with 120 years of antibiotics focus: "We have to expand" (medwatch.com)
2026-10-06 — Press Release: Xellia and Hisun sign strategic global multiple-API partnership | Zhejiang Hisun Pharmaceutical (linkedin.com)
2026-03-31 — 📢🏭 Congratulations to Rolla Group on the successful sale of its industrial site in Szigetszentmiklós to Xellia Pharmaceuticals. The transaction includes a 36,000 sqm plot and a 5,100 sqm industrial facility, set … | Colliers (linkedin.com)
2026-03-06 — New Pharmaceutical Industry Investment in Hungary | Diplomacy & Trade (dteurope.com)
Facilities
Xellia Pharmaceuticals is headquartered in Copenhagen, Capital Region of Denmark. Public sources also reference these locations:
Denmark, Norway — munters.com
Cleveland, Ohio — businesswire.com
Copenhagen, Denmark — pharmacompass.com
Denmark — pharmacompass.com
Company details
Xellia is owned by Novo Holdings and employs approximately 1,800 people across its global operations. Xellia Pharmaceuticals was founded in 1903, has an estimated 1,000-5,000 employees, and is headquartered in Copenhagen, Capital Region of Denmark.
Frequently asked questions
What does Xellia Pharmaceuticals do?
Xellia Pharmaceuticals, headquartered in Copenhagen and founded in 1903, is a specialty pharmaceutical manufacturer with 1,000–5,000 employees. The company produces fermentation-based non-beta-lactam anti-infectives, active pharmaceutical ingredients, and injectable formulations, serving medical, healthcare, and critical-care sectors. In March 2026, Xellia acquired an industrial facility in Hungary to expand manufacturing capacity.
Where is Xellia Pharmaceuticals headquartered?
Xellia Pharmaceuticals is headquartered in Copenhagen, Capital Region of Denmark (11 Dalslandsgade, Copenhagen, Capital Region of Denmark, 2300).
When was Xellia Pharmaceuticals founded?
Xellia Pharmaceuticals was founded in 1903.
How big is Xellia Pharmaceuticals?
Xellia Pharmaceuticals has an estimated 1,000-5,000 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
